475 Inflammasome and Extracellular Vesicle Biomarkers in CSF and Serum Predict Systemic Outcomes After Spinal Cord Injury

View at publisher Summarise with VIRAT
Authors: Shray Mehra, Stephen Shelby Burks, Emily L. Errante, Ericka A. Schaeffer, Nadine A. Kerr, Juan Pablo de Rivero Vaccari, Allan D. Levi, Seth Tigchelaar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Traumatic spinal cord injury (SCI) initiates a cascade of local and systemic inflammation that affects multiple organ systems. While initial spinal cord damage is often the clinical focus, secondary complications in cardiovascular, pulmonary, and gastrointestinal systems drive long-term morbidity and mortality. Current diagnostic tools (e.g., MRI) are costly and lack predictive power. This study investigates cerebrospinal fluid (CSF) and serum biomarkers—particularly inflammasome proteins and extracellular vesicles (EVs)—as indicators of systemic complications and outcomes in SCI patients. METHODS: A cohort of 20 patients with acute cervical SCI and 10 matched non-inflammatory controls (e.g., hydrocephalus) will be enrolled. CSF and serum samples will be collected perioperatively through clinically indicated lumbar drains. Samples will be analyzed for inflammasome proteins (caspase-1, ASC, IL-1β, IL-18) using multiplex technologies (Ella SimplePlex, Simoa HD-X), and CNS injury biomarkers (GFAP, UCHL1, tau, Nf). EVs will be isolated and profiled for organ-specific markers using flow cytometry. Serum analyses will parallel CSF profiling. Preliminary predictive modeling correlates biomarker levels with systemic complications (e.g., respiratory failure, cardiac events) using logistic regression and random forest algorithms. RESULTS: Preliminary pilot data demonstrate significantly elevated levels of inflammasome proteins in SCI CSF compared to controls. EV analysis reveals signatures of lung, liver, and cardiac injury. These findings support the utility of CSF and serum biomarkers as early indicators of systemic organ involvement. Modeling based on these markers is underway, using longitudinal outcomes from historical SCI datasets. CONCLUSIONS: Inflammasome and EV profiling in CSF and serum provides a minimally invasive strategy for early identification of systemic complications following SCI. These biomarkers may enable proactive, personalized management and represent a key step toward predictive diagnostics in SCI care.

Fields of Study & Subjects

Spinal Cord Injury Research Traumatic Brain Injury and Neurovascular Disturbances Extracellular vesicles in disease

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
139–139
Publication date
26 March 2026
Language
EN